verall survival curves from the initiation of treatment for metastatic UC. Overall, the median OS was 00 months from the initiation of treatment for metastases in the MSC cohort, as compared with 00 months in the non-MSC cohort (Figure [0](#hyz000F0){ref-type="fig"}a, *P* \< 0.0000). A